Jeffrey M. Holzbeierlein, MD of University of Kansas Hospital discusses his presentation, “Orphan Cancers with Opportunities for Improved Treatment (ARS)” and how his data will affect clinicians in the same field at the 2017 Genitourinary Cancers Symposium (Annual Meeting GU) in Orlando, Florida.
Orphan Cancers: How Might the Data Affect Clinicians in the Field
